Search clinical trials for: Xience V/Prime stent

Total 154 results

Sino Medical Sciences Technology Inc.

Completed

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

Coronary Artery Disease | Stable Angina Pectoris | Unstable Angina Pectoris

China
Universitaire Ziekenhuizen KU Leuven
Biosensors International

Unknown

COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study (COBRA)

True Coronary Bifurcation Lesions

Belgium
Odense University Hospital

Completed

The SOURT OUT IV TRIAL (SORT OUT IV)

Ischemic Heart Disease | Percutaneous Coronary Intervention | Coronary Atherosclerosis

Denmark
Policlinico Casilino ASL RMB
Azienda Ospedaliero-Universitaria di Modena

Withdrawn

Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus (OCELOT)

Coronary Artery Disease | Diabetes Mellitus

Italy
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

France, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
Aarhus University Hospital Skejby
Medtronic; Abbott Medical Devices

Unknown

The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study (DOCTOR Recross)

Coronary Disease

United Kingdom, Belgium, Denmark
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents (ISAR-TEST6)

Coronary Heart Disease

Germany
Flanders Medical Research Program

Completed

Drug Eluting Stents In The Critically Ischemic Lower Leg 2 (DESTINY 2)

Peripheral Arterial Disease

Germany, Australia, Belgium
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus (ESSENCE-DM)

Coronary Artery Disease

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
Odense University Hospital

Completed

Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients (DIABEDES IV)

Diabetes Mellitus

Denmark
Sydney South West Area Health Service

Unknown

IVUS Controlled Stenting

Coronary Angioplasty and Stenting | Single de Novo Coronary Artery Stenoses

Australia
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
European Hospital

Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease (RENAL-DES)

Chronic Kidney Disease | Multivessel Coronary Artery Disease

Italy
Deutsches Herzzentrum Muenchen

Completed

Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography (TEST-6-OCT)

Coronary Heart Disease

Germany
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Terminated

LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

Coronary Artery Disease

Korea, Republic of
Deutsches Herzzentrum Muenchen

Unknown

Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World (ZEPPELIN)

Coronary Artery Disease

Germany
Abbott Medical Devices

Completed

SPIRIT PRIME Clinical Trial (SPIRIT PRIME)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Coronary Artery Stenosis

United States, Australia
Abbott Medical Devices

Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angina

Japan
North Texas Veterans Healthcare System

Completed

Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions (SOS-Xience V)

Coronary Artery Bypass | Atherosclerosis

United States
European Cardiovascular Research Center

Unknown

Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization (PLATINUM+)

Ischemic Heart Disease | Coronary Artery Stenosis

Spain, Germany, France, United Kingdom, Italy, Netherlands, Macedonia, The Former Yugoslav Republic of, Switzerland
Foundation of Cardiovascular Research and Education...

Completed

The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente (TWENTE)

Coronary Artery Disease | Angina Pectoris | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
Korea University Anam Hospital
Korea University Guro Hospital; Yonsei University; Kyungpook National University... and other collaborators

Unknown

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial ) (Restenosis)

In-stent Arterial Restenosis

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Yonsei University
Gangwon Cardiovascular Health Research Institute

Terminated

BES, EES, and ZES-R in Real World Practice (CHOICE)

Coronary Artery Disease

Korea, Republic of
Seoul National University Hospital

Completed

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents (Grand-DES)

Coronary Artery Disease

Korea, Republic of
OrbusNeich
Genae

Completed

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT (REMEDEE-OCT)

Coronary Artery Disease | Atherosclerosis | Acute Coronary Syndrome (ACS) | Myocardial Infarction (MI)

United Kingdom, Netherlands, Finland, Belgium, Switzerland
Abbott Medical Devices

Completed

XIENCE PRIME Japan Post-Marketing Surveillance (PMS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Occlusion | Coronary Artery Stenosis | Angina

Japan
University Hospital Heidelberg

Completed

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Coronary Artery Disease
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography (ORSIRO_OCT)

Coronary Heart Disease

Germany
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Medtronic Vascular
Medtronic Bakken Research Center

Completed

Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent (RESOLUTE-AC)

Coronary Artery Disease

Switzerland
Amsterdam UMC, location VUmc

Unknown

Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion:a Randomized H215O PET/CT Study (VANISH)

Coronary Artery Disease

Netherlands
Cardiovascular Research Foundation, New York
Dickson Advanced Analytics Group

Completed

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents (ADAPT-DES)

Coronary Artery Disease

United States
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
Kobe University
Marquette University

Unknown

Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)

Coronary Heart Disease

Japan
University Hospital, Basel, Switzerland

Completed

Safety and Efficacy Study Comparing 3 New Types of Coronary Stents

Coronary Artery Disease | Coronary Thrombosis

Denmark, Austria, Germany, Switzerland
San Giuseppe Moscati Hospital

Completed

Everolimus Stent in Patients With Coronary Artery Disease (CAD) (RACES)

Coronary Artery Disease | Coronary Atherosclerosis

Italy
Abbott Medical Devices

Completed

Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France (Far XIENCE V®)

Coronary Artery Disease

France
Micell Technologies
Yale Cardiovascular Research Group; North American Science Associates Inc.; Baim...

Not yet recruiting

Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. (CRYSTAL)

Coronary Artery Disease
Chonbuk National University Hospital

Unknown

COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease (COPERES)

Angioplasty, Balloon, Coronary

Korea, Republic of
Brighton and Sussex University Hospitals NHS Trust
Abbott Medical Devices

Completed

Xience or Vision Stent Management of Angina in the Elderly (XIMA)

Coronary Artery Disease

United Kingdom
Universitaire Ziekenhuizen KU Leuven

Withdrawn

COmplex BifuRcation Lesions: A Comparison Between the AXXESS Device and Culotte Stenting: An Optical Coherence Tomography (OCT) Study (COBRA)

Coronary Artery Stenosis

Belgium
R&D Cardiologie
Biotronik SE & Co. KG

Unknown

Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions (PRISON-IV)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands, Belgium
Kobe University

Unknown

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent

Coronary Artery Disease

Japan
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial (AIDA)

Myocardial Infarction | Coronary Artery Disease

Netherlands
Harbin Medical University

Unknown

Evaluation of Neointimal Coverage of EES and BMS After Implantation in STEMI Patients by Optical Coherence Tomography (NeoCover)

Acute Myocardial Infarction

China
The Hospital District of Satakunta

Completed

Coronary Flow Reserve in Patients With Bio-active Stent or Everolimus-eluting Stent Implanted in Acute Coronary Syndrome (BASE-CFR)

Acute Coronary Syndrome

Finland
Yonsei University

Unknown

Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation (ANCHOR)

Coronary Artery Disease

Korea, Republic of

Search clinical trials for: Xience V/Prime stent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations